NGM BIOPHARMACEUTICALS INC revenue breakdown overview

NGM BIOPHARMACEUTICALS INC revenue for the last year amounted to 4.00 M EUR, the most of which — 4.00 M EUR — came from its highest performing source at the moment, Medicines, the year earlier bringing 51.70 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought NGM BIOPHARMACEUTICALS INC 4.00 M EUR, and the year before that — 51.70 M EUR.